Nautilus Biotechnolgy, Inc. (NAUT) vs Vogenx Inc. (VOGX)

A side-by-side comparison of Nautilus Biotechnolgy, Inc. and Vogenx Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NAUT

Nautilus Biotechnolgy, Inc.

$225M

$1.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VOGX

Vogenx Inc.

$228M

$16.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — NAUT vs VOGX

growth of $100 · dividends reinvested · last 1y

NAUT +109.9% (+109.9%/yr)VOGX +31.9% (+31.9%/yr)NAUT compounded faster over this window

NAUT VOGX

Metrics side by side

Total return (annualized)

Metric	NAUT	VOGX
Total return (1Y)	111.12%	N/A
Total return CAGR (3Y)	-15.27%	N/A
Total return CAGR (5Y)	-20.56%	N/A

VOGX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full NAUT analysis Full VOGX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.